Gitte Pedersen is a Danish scientist and company builder using mRNA to design next generation cures for cancer. Together with her brother, she co-founded Genomic Expression where the familial tale extends into the startup’s origin story.

In this episode, co-host @kyle kruse and I discover what led Gitte to tackle the significant issue faced by many cancer sufferers in the world. The lack of specificity that recognized therapeutics provide for cancer, or sometimes, the lack of any available treatment option at all.

Genomic’s OneRNA platform enables repurposing existing drugs even on an individual patient basis and the development of novel RNA therapeutics. We learn how the platform is targeting both ends of the spectrum with their first indication, Breast cancer, the most common type of cancer, as well as building studies for rare types where 40,000 or less patients are affected. It's worth highlighting that these rare types account for a quarter of all cancers in the US!

As recent applications of mRNA vaccines and AI-driven healthcare solutions have shown, there is finally a possibility for the rapid development of personalized and more effective treatments. This paradigm shift in medicine makes the work of Genomic Expression well worth a listen to learn more about!